Repare Therapeutics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
June 08 2023 - 7:00AM
Business Wire
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq:
RPTX), a leading clinical-stage precision oncology company, today
announced that members of its senior management team will
participate in a fireside chat at the Goldman Sachs 44th Annual
Global Healthcare Conference on Wednesday, June 14, 2023 at 2:00
p.m. Pacific Time/ 5:00 p.m. Eastern Time in Dana Point,
California.
A live webcast of the fireside chat can be accessed in the
Investor section of the Company’s website at
https://ir.reparerx.com/news-and-events/events. A replay of the
webcast will be archived on the Company’s website for 90 days.
About Repare Therapeutics, Inc.
Repare Therapeutics is a leading clinical-stage precision
oncology company enabled by its proprietary synthetic lethality
approach to the discovery and development of novel therapeutics.
The Company utilizes its genome-wide, CRISPR-enabled SNIPRx®
platform to systematically discover and develop highly targeted
cancer therapies focused on genomic instability, including DNA
damage repair. The Company’s pipeline includes lunresertib (also
known as RP-6306), a PKMYT1 inhibitor currently in Phase 1 clinical
development; camonsertib (also known as RP-3500 or RG6526), a
potential leading ATR inhibitor currently in Phase 1/2 clinical
development and partnered with Roche; a preclinical Polθ inhibitor
program; as well as several additional, undisclosed preclinical
programs, including RP-1664. For more information, please visit
reparerx.com.
SNIPRx® is a registered trademark of Repare Therapeutics
Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230608005101/en/
Repare Contact: Robin Garner Executive Director and Head
of Investor Relations Repare Therapeutics Inc.
investor@reparerx.com
Investors: Matthew DeYoung Argot Partners
repare@argotpartners.com
Media: David Rosen Argot Partners
david.rosen@argotpartners.com 212-600-1902
Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From Apr 2024 to May 2024
Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From May 2023 to May 2024